Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.35
+0.14 (0.42%)
Mar 27, 2025, 4:00 PM EST - Market closed
HRMY Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for HRMY stock have an average target of 54, with a low estimate of 40 and a high estimate of 70. The average target predicts an increase of 61.92% from the current stock price of 33.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $42 → $44 | Buy | Maintains | $42 → $44 | +31.93% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $70 | Strong Buy | Maintains | $75 → $70 | +109.90% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +49.93% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +49.93% | Feb 25, 2025 |
| Mizuho | Mizuho | Buy Maintains $52 → $42 | Buy | Maintains | $52 → $42 | +25.94% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
864.24M
from 714.73M
Increased by 20.92%
Revenue Next Year
1.03B
from 864.24M
Increased by 18.83%
EPS This Year
3.38
from 2.51
Increased by 34.61%
EPS Next Year
4.57
from 3.38
Increased by 35.25%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 934.3M | 1.1B | 1.4B | ||
| Avg | 864.2M | 1.0B | 1.2B | ||
| Low | 803.5M | 915.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.7% | 29.8% | 36.6% | ||
| Avg | 20.9% | 18.8% | 20.7% | ||
| Low | 12.4% | 5.9% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.37 | 5.76 | 8.87 | ||
| Avg | 3.38 | 4.57 | 8.15 | ||
| Low | 1.90 | 3.13 | 7.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 74.0% | 70.6% | 94.2% | ||
| Avg | 34.6% | 35.2% | 78.3% | ||
| Low | -24.3% | -7.5% | 61.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.